Get the Stockscreener App
8.04
7.59%
-0.66
After Hours:
8.00
-0.04
-0.50%
Aclarion Inc stock is traded at $8.04, with a volume of 42,315.
It is down -7.59% in the last 24 hours and up +5.42% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$8.70
Open:
$8.37
24h Volume:
42,315
Relative Volume:
0.36
Market Cap:
$4.68M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.8845
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-6.48%
1M Performance:
+5.42%
6M Performance:
-10.47%
1Y Performance:
+74.85%
1-Day Range:
$8.00
$8.37
1-Week Range:
$8.00
$12.03
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
8.04 | 5.07M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
283.73 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
87.78 | 15.81B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.57 | 12.61B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.46 | 7.84B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Stock (ACON) Latest News
Can B N Rathi Securities Limited Outperform Index Funds Over the Next 5 YearsVolatility Adjusted Trading & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Why hedge funds are buying Aclarion Inc. stockWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Is this a good reentry point in Aclarion Inc. Equity WarrantBear Alert & Expert Curated Trade Setups - newser.com
What technical models suggest about Aclarion Inc.’s comebackWeekly Trade Report & AI Enhanced Market Trend Forecasts - newser.com
Technical analysis overview for Aclarion Inc. stockJuly 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Will Aclarion Inc. Equity Warrant stock recover faster than peersEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Will Aclarion Inc. Equity Warrant continue its uptrendWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com
Is Aclarion Inc. Equity Warrant stock a smart buy before Fed meetingPortfolio Gains Report & Smart Investment Allocation Insights - nchmf.gov.vn
How to forecast Aclarion Inc. trends using time seriesJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Pattern recognition hints at Aclarion Inc. Equity Warrant upsideQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Will Aclarion Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Why Aclarion Inc. stock attracts high net worth investorsTrade Entry Report & Long-Term Safe Investment Ideas - nchmf.gov.vn
Can Aclarion Inc. Equity Warrant stock maintain operating marginsJuly 2025 Patterns & AI Optimized Trade Strategies - nchmf.gov.vn
Why retail investors pile into Aclarion Inc. stockJuly 2025 Earnings & Fast Gaining Stock Reports - nchmf.gov.vn
Why Aclarion Inc. Equity Warrant stock could rally in 2025Long Setup & Weekly High Return Stock Opportunities - newser.com
Why Aclarion Inc. Equity Warrant stock is favored by top institutionsQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Why Aclarion Inc. stock could see breakout soonJuly 2025 Volume & Scalable Portfolio Growth Methods - nchmf.gov.vn
Regression analysis insights on Aclarion Inc. performance2025 Top Gainers & Verified Momentum Stock Alerts - newser.com
Is it time to cut losses on Aclarion Inc. Equity Warrant2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
Is Aclarion Inc. stock ready for a breakoutWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Risk vs reward if holding onto Aclarion Inc. Equity WarrantMarket Performance Recap & Safe Entry Momentum Tips - newser.com
What MACD signals say about Aclarion Inc.Weekly Trade Analysis & Safe Swing Trade Setups - newser.com
How geopolitical risks impact Aclarion Inc. (IT20) stock2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Does Aclarion Inc. Equity Warrant show high probability of reboundWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Aclarion reports 89% increase in Nociscan scan volumes in Q3 By Investing.com - Investing.com Australia
Aclarion Announces Securities Purchase Agreement for $2.5M - TipRanks
Aclarion IncClarity trial on schedule, early readouts expected Q2 2026 - MarketScreener
Aclarion, Inc. Reports Strong Financial Position and Record Growth in Nociscan Utilization Amid Ongoing CLARITY Trial Progress - Quiver Quantitative
Aclarion reports 89% increase in Nociscan scan volumes in Q3 - Investing.com
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst - The Manila Times
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Aclarion (NASDAQ:ACON) Stock Price Up 12.7% – What’s Next? - Defense World
Aclarion Inc Stock Analysis and ForecastInsider Selling Patterns & Invest Now – Opportunity Window Closing - earlytimes.in
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.45%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):